Viracta Therapeutics (VIRX)
NASDAQ:VIRX

Viracta Therapeutics (VIRX) Similar Stocks

837 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Viracta Therapeutics
$21.13M
-0.43
-64.19%
3 Buy
0 Hold
0 Sell
Strong Buy
$7.33
Kura Oncology
$1.71B
-10.29
123.45%
8 Buy
1 Hold
0 Sell
Strong Buy
$30.63
MacroGenics
$294.38M
-12.53
-6.93%
6 Buy
4 Hold
0 Sell
Moderate Buy
$11.11
Arrowhead Pharmaceuticals
$3.49B
-6.63
-18.99%
7 Buy
4 Hold
0 Sell
Moderate Buy
$45.70
Seres Therapeutics
$162.05M
-1.76
-74.95%
2 Buy
2 Hold
0 Sell
Moderate Buy
$4.08

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
VIRX
Viracta Therapeutics
0.53
-0.95
-64.19%
KURA
Kura Oncology
22.77
12.99
132.82%
MGNX
MacroGenics
4.83
0.35
7.81%
ARWR
Arrowhead Pharmaceuticals
28.86
-6.97
-19.45%
MCRB
Seres Therapeutics
1.19
-3.23
-73.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis